entertainment -WSS

entertainment

author：fashion 2025-09-30 00:03:43 - browse：8

Adderall XR capsules are displayed on Feb. 24, 2023. Drug shortages are growing in the United States, and experts see no clear path to resolving them. — There has been a persistent shortage of the ADHD drug Adderall. Jenny Kane/AP

My first exposure to pharmaceutical shortages happened in 2017 as a new-to-practice nurse working on an inpatient oncology unit. A hurricane in Puerto Rico had left the U.S. short of sodium chloride minibags. Health care providers nationwide were tasked to modify standard medication preparation and administration practices, such as changing medications from IV to oral delivery, avoiding prepping IV lines with saline, or providing IV drugs by push rather than infusion. I was working in a heavily resourced academic institution. It felt absurd that I couldn’t even appropriately administer medications, but I figured this was an emergency.

Eventually, the shortage ended. But it was not an isolated incident.

The recent spotlight on shortages of essential medicines, such as cancer therapies and ADHD drugs, has brought attention to a longstanding public health crisis. Prescription drug shortages across drug classes have been on the radar of our governing bodies for decades. Nearly 10 years ago, up to 83% of oncologists surveyed could not prescribe a preferred chemotherapy agent due to shortages. Yet, the problem persists, with new shortages being identified at alarming rates. Recent reports indicate drug shortages grew by 30% in the past year. At the end of 2022, there were national shortages of 295 medications, including essentials like anesthetics, chemotherapies, and antibiotics.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： Ransomware attacks on hospitals: Study outlines patient impact

knowledge

focus

WSS

Delfi Diagnostics unveils key aspects of liquid biopsy test for lung cancer

Readout Newsletter: What is Casgevy? Does Wegovy hurt muscle?

ASCO Takeaways: Winners, snoozers, and the art of cancer care

Morphosys mixed study results for blood cancer drug

Finland to offer bird flu vaccine to select groups of people, a possible global first

Eli Lilly’s Zepbound improved liver scarring in mid

explore

entertainment

knowledge

Drug repurposing or repositioning? The language matters

Readout Newsletter: The latest at Gilead, Catalent, and the NIH

Medical records are filled with copy

ASCO Daily Recap: CAR

Moonlake's readout produced a cash windfall. Risks remain

David Sabatini, ex

Walensky prepares to leave CDC — and Congress — behind

Anthos stroke drug appears safer than common blood thinner

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

CMS got Medicare Advantage quality rating wrong, judge rules

entertainment

CMS got Medicare Advantage quality rating wrong, judge rules

Anthos stroke drug appears safer than common blood thinner

FDA approves Moderna’s RSV vaccine, its second licensed product

Take antibiotics after sex, CDC recommends for certain risk groups

PBM reforms clear House panel

Congress must reauthorize a committee to support older Americans

focus

focus

explore

leisure time